Strategic Pharmacovigilance Outsourcing Models

Larger companies often limit their strategic pharmacovigilance activities outsourcing only to highly manual and repetitive tasks, while the smaller ones may want to outsource their entire pharmacovigilance system. But is there anything in between?

  • How can larger companies benefit from outsourcing strategic pharmacovigilance activities while maintaining full control and compliance?
  • How can small/medium-sized companies get access to a serious pharmacovigilance database that grows with them without having to break the bank?
  • What are the advantages of scalable and tailor-made outsourcing models?
  • How can the pharmaceutical companies obtain benefits from the scalability and standardization required to ensure central oversight while also retaining local effectiveness?

 

You will learn about strategic pharmacovigilance activities outsourcing through scalable and tailor-made outsourcing models and how it can be done in a controlled way:

 

1. Full pharmacovigilance outsourcing

  • What does it mean?
  • How will you remain in control?

2. Outsourcing a pharmacovigilance database

  • How to select a proper database?
  • How to get access to it without buying it yourself?
  • What control levels can you opt for?

3. Outsourcing specific strategic pharmacovigilance activities

  • How to remain in control?

Optimizing your pharmacovigilance activities?

Make use of our experts’ invaluable know-how in managing pharmacovigilance activities while remaining in control.

Who should attend?

  • Global QPPVs / Deputies
  • QPPV Office managers
  • Heads of Pharmacovigilance
  • Heads of Pharmacovigilance Technologies
  • Drug Safety Managers
  • Drug Safety Leaders involved in Risk Management, Aggregate Safety reports, Oversight and Standards

Duration: 50 min.

Speakers:

  • Head of Global Pharmacovigilance, Martijn van de Leur;
  • International QPPV, Olga Asimaki;
  • QPO Manager and Head of Pharmacovigilance Technologies, Gediminas Zvicevičius.
Martijn van de Leur, MSc

Martijn van de Leur, MSc

Head of Global Pharmacovigilance

Other content that might interest you:

Affiliate Based Outsourcing Model for Regulatory Affairs.

Affiliate Based Outsourcing Model for Regulatory Affairs.

 Affiliate based Outsourcing Model for Regulatory Affairs works as a replacement or an extension of the company’s internal and local RA resources. Many challenges come up from managing your RA activities as sometimes their processes are not harmonized across different...

read more
Regulatory Outsourcing in the CEE Region

Regulatory Outsourcing in the CEE Region

In this informative session we decode the intricate landscape of regulatory affairs outsourcing in the CEE region and provide practical, implementable strategies to optimize and maximize your operations and outsourcing strategies.Let’s discuss how we can streamline...

read more
Regulatory Framework of Drugs in MENA: Insights

Regulatory Framework of Drugs in MENA: Insights

In this webinar, our experts discuss regulatory affairs of medicinal products. Two aspects that have recently gained increasing importance among the various stakeholders, namely the eCTD implementation across the region and the serialization and barcoding requirements...

read more
Breaking silos across Medical Information & Pharmacovigilance

Breaking silos across Medical Information & Pharmacovigilance

Discover solutions for effective PV & MI data management, including handling Adverse Events, Product Quality Complaints, and MI inquiries. Our experts will walk you through real-life examples and hands-on solutions. Looking to improve your PV & MI data...

Exploring Regulatory, Inspection, and Cultural PV Trends in APAC

Exploring Regulatory, Inspection, and Cultural PV Trends in APAC

In our latest discussion, Albert Bekfi, Head of Global Pharmacovigilance Operations at Biomapas, is joined by Theo Giannou and Wee Chuan Lau from Bloom Agents, a regional pharmacovigilance service provider with over 30 years’ experience across Asia-Pacific (APAC)....

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information